Zobrazeno 1 - 10
of 97
pro vyhledávání: '"Daniel, Dietrich"'
Autor:
Petersson, Christopher a, ⁎, Szakalos, Peter a, Pettersson, Rachel a, b, Stein, Daniel Dietrich c
Publikováno v:
In Journal of Nuclear Materials January 2024 588
Publikováno v:
Nuclear Materials and Energy, Vol 34, Iss , Pp 101403- (2023)
The susceptibility of Fe-10Cr-4Al steel to liquid metal embrittlement (LME) in low oxygen liquid lead and lead–bismuth eutectic (LBE) environments has been investigated using a newly developed slow strain rate testing (SSRT) technique that can be e
Externí odkaz:
https://doaj.org/article/b25dfbdc7dc1471e9fc2ddaa008ca499
Autor:
Daniel Dietrich
Build your web applications from the ground up with the Play Framework for Java and ScalaKey FeaturesLearn something new in an Instant! A short, fast, focused guide delivering immediate results.Get started with Play 2.1Build your own web application
Autor:
Karin Ribi, Beat Thürlimann, Corinne Schär, Daniel Dietrich, Richard Cathomas, Ursina Zürrer-Härdi, Thomas von Briel, Sandro Anchisi, Pierre Bohanes, Veronika Blum, Philippe von Burg, Meinrad Mannhart, Clemens B. Caspar, Roger von Moos, Michael Mark
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background Bone-targeted agents (BTAs) are widely used in the management of patients with bone metastases from solid tumors. Knowledge of the impact of their routine care use on patient-reported pain and bone pain-related quality of life (Qo
Externí odkaz:
https://doaj.org/article/2f4e37bedf8d49deba6179a01a81e7f8
Autor:
Serenella Eppenberger-Castori, Dirk Klingbiel, Thomas Ruhstaller, Daniel Dietrich, Daniel Alexander Rufle, Karin Rothgiesser, Olivia Pagani, Beat Thürlimann
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-9 (2020)
Abstract Background The HER2 extracellular domain shed in blood (HER2ECD) is reported to rise and fall in parallel with HER2+ breast cancer behavior. In this study, we evaluated the clinical relevance of plasma HER2ECD values in patients with metasta
Externí odkaz:
https://doaj.org/article/3e2f1998662b4126856dd5c1de79bb5b
Autor:
Sandro T. Stoffel, Roger von Moos, Beat Thürlimann, Richard Cathomas, Silke Gillessen, Ursina Zürrer-Härdi, Thomas von Briel, Sandro Anchisi, Anita Feller, Corinne Schär, Daniel Dietrich, Matthias Schwenkglenks, Judith E. Lupatsch, Michael Mark
Publikováno v:
Swiss Medical Weekly, Vol 151, Iss 0910 (2021)
BACKGROUND International guidelines state that bone-targeted agents such as denosumab or zoledronic acid at doses used for bone metastasis are not indicated for patients with metastatic castration-sensitive prostate cancer (mCSPC) with bone metastas
Externí odkaz:
https://doaj.org/article/df3a8a388f13484995705aee9f4b2605
Autor:
Michael Mark, Beat Thürlimann, Karin Ribi, Corinne Schär, Daniel Dietrich, Richard Cathomas, Ursina Zürrer-Härdi, Thomas von Briel, Sandro Anchisi, Pierre Bohanes, Veronika Blum, Philipp von Burg, Meinrad Mannhart, Clemens B Caspar, Roger von Moos
Publikováno v:
Journal of Bone Oncology, Vol 21, Iss , Pp - (2020)
Background: Bone-targeted agents (BTAs) are widely used in the management of patients with bone metastases from solid tumors, but knowledge of their routine care use and the therapeutic implications remains limited. This non-interventional study aime
Externí odkaz:
https://doaj.org/article/0e77d4190fbb434184b3402e30ef62de
Publikováno v:
PiD - Psychotherapie im Dialog. 23:96-101
Aufgewachsen ohne jeglichen Kontakt zu Gleichaltrigen, wusste sie nicht, dass etwas ungewöhnlich war in ihrem Leben. Jahrelang ignorierte sie Zeitlücken und Verletzungen an ihrem Körper. Die Vergewaltigungen durch den Vater, den Hass und die Schl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f4e6f18b58d66452a3f8ab89a01c33f5
https://doi.org/10.1055/a-1711-8637
https://doi.org/10.1055/a-1711-8637
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Piera Gargiulo, Daniel Dietrich, Richard Herrmann, György Bodoky, Thomas Ruhstaller, Werner Scheithauer, Bengt Glimelius, Simona Berardi, Sandro Pignata, Peter Brauchli
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 11 (2019)
Background: The prognosis of advanced pancreatic cancer (APC) is poor and differs considerably among patients. Therefore, it is clinically relevant to identify patients with APC who are more likely to benefit from palliative chemotherapy with reduced
Externí odkaz:
https://doaj.org/article/c7101935ef0a475194e2948bbddd2239